Drug Type Small molecule drug |
Synonyms SRI31215 |
Mechanism HGF stimulants(Hepatocyte growth factor stimulants), HGFA inhibitors(HGF activator inhibitors), hepsin inhibitors(Serine protease hepsin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 24 Dec 2015 |